61 episodes

A weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. To claim pharmacology CE credit or to get a copy of presentation slides, visit https://ce.mayo.edu/pharmacypodcast. Produced by @MayoMedEd. Hosted by @garrett_schramm

Mayo Clinic Pharmacy Grand Rounds Mayo Clinic

    • Education
    • 5.0 • 1 Rating

A weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. To claim pharmacology CE credit or to get a copy of presentation slides, visit https://ce.mayo.edu/pharmacypodcast. Produced by @MayoMedEd. Hosted by @garrett_schramm

    Probiotics or Conbiotics: Probiotic Use in Preterm Neonates

    Probiotics or Conbiotics: Probiotic Use in Preterm Neonates

    Brandi N. Smith, PharmD, BCPPS defines necrotizing enterocolitis and late-onset sepsis in the premature neonate and proposed mechanisms of prevention with probiotic use, reviews literature supporting the use of probiotics in premature neonates and recognizes ongoing questions in using probiotics in premature neonates.


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 46 min
    Targeted Oral Chemotherapy Agents for Metastatic Breast Cancer

    Targeted Oral Chemotherapy Agents for Metastatic Breast Cancer

    Kaitlyn J. Bailey, PharmD (@pharmgirl1821) describes the mechanisms of action of select CDK46, PI3K, and PARP inhibitors, reviews the outcomes data related to CDK46, PI3K, and PARP inhibitors for treatment of metastatic breast cancer and discusses toxicity management for CDK46, PI3K, and PARP inhibitors. 


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 36 min
    Shall We Bival? Use of Bivalirudin for Anticoagulation in Pediatric ECMO

    Shall We Bival? Use of Bivalirudin for Anticoagulation in Pediatric ECMO

    Mai Uyen Alissa Le, PharmD describes the utility and importance of anticoagulation in ECMO, identifies clinical factors to consider with the use of bivalirudin anticoagulation in ECMO and discusses literature evaluating the use of bivalirudin and its comparison to heparin for anticoagulation in pediatric patients supported on ECMO. 


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 43 min
    Less is More: Integrating Deprescribing in the Inpatient Setting

    Less is More: Integrating Deprescribing in the Inpatient Setting

    Joseph C. Osborne III, PharmD (@JOzempic) describes the current framework of deprescribing, reviews literature pertinent to deprescribing in the inpatient setting and identifies facilitators, barriers, and future directions for deprescribing.


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 41 min
    Mr. COVID & MIS-C: One Toxic Relationship

    Mr. COVID & MIS-C: One Toxic Relationship

    Natalie A. Haddad, PharmD (@NatalieHaddadRx) describes the epidemiology of multisystem inflammatory syndrome in children (MIS-C), outlines key similarities and differences between MIS-C and other comparable pediatric conditions and discusses current potential therapeutic options for the treatment of MIS-C.


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 30 min
    Blast from the BARBiturate Past: Phenobarbital for Alcohol Withdrawal Syndrome

    Blast from the BARBiturate Past: Phenobarbital for Alcohol Withdrawal Syndrome

    Kyle S. Wamsley, PharmD (@KyleWamsley1) describes the pathophysiology and complications associated with alcohol withdrawal syndrome (AWS), reviews treatment modalities and commonly utilized agents for AWS in the ICU setting and outlines appropriate phenobarbital dosing regiments based on current literature. 


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 34 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

Top Podcasts In Education

You Might Also Like

More by Mayo Clinic